Chemical pathology of acute demyelinating lesions and its correlation with disability

被引:255
作者
DeStefano, N
Matthews, PM
Antel, JP
Preul, M
Francis, G
Arnold, DL
机构
[1] MONTREAL NEUROL HOSP & INST, DEPT NEUROL & NEUROSURG, MONTREAL, PQ H3A 2B4, CANADA
[2] MCGILL UNIV, DEPT HUMAN GENET, MONTREAL, PQ, CANADA
关键词
D O I
10.1002/ana.410380610
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We report the chemical pathological changes on magnetic resonance spectroscopic images of 4 patients, each of whom had a single large demyelinating plaque. The patients were followed from soon after the onset of the symptoms for a minimum of 7 months to a maximum of 31/2 years. We observed increases in the relative resonance intensities of choline-containing compounds, lactate, and myo-inositol inside the lesion acutely. Decreases in relative resonance intensities of N-acetylaspartate and creatine were seen both in and around the magnetic resonance imaging-detected lesions. In all patients neurological deficits improved and creatine, lactate, and myo-inositol resonance intensities normalized during the follow-up. Choline compounds recovered more slowly and were still abnormally high in 1 patient after 7 months. Partial recovery of the N-acetylaspartate resonance was seen for all patients. Evaluation of the relationships between indices of cerebral chemical pathology, brain lesion volumes, and functional disability showed highly significant negative correlations between N-acetylaspartate resonance intensities and both brain lesion volumes (r = -0.80, P < 0.0001) and clinical disability (r = -0.73, P < 0.0001). As N-acetylaspartate is localized solely in neurons in the adult central nervous system, our results suggest that neuronal dysfunction may be a proximate mechanism of disability even in inflammatory disorders primarily affecting myelin and oligodendroglial cells.
引用
收藏
页码:901 / 909
页数:9
相关论文
共 37 条
[1]   PROTON MAGNETIC-RESONANCE SPECTROSCOPY OF HUMAN BRAIN INVIVO IN THE EVALUATION OF MULTIPLE-SCLEROSIS - ASSESSMENT OF THE LOAD OF DISEASE [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, G ;
ANTEL, J .
MAGNETIC RESONANCE IN MEDICINE, 1990, 14 (01) :154-159
[2]   USE OF PROTON MAGNETIC-RESONANCE SPECTROSCOPY FOR MONITORING DISEASE PROGRESSION IN MULTIPLE-SCLEROSIS [J].
ARNOLD, DL ;
RIESS, GT ;
MATTHEWS, PM ;
FRANCIS, GS ;
COLLINS, DL ;
WOLFSON, C ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1994, 36 (01) :76-82
[3]   PROTON MAGNETIC-RESONANCE SPECTROSCOPIC IMAGING FOR METABOLIC CHARACTERIZATION OF DEMYELINATING PLAQUES [J].
ARNOLD, DL ;
MATTHEWS, PM ;
FRANCIS, GS ;
OCONNOR, J ;
ANTEL, JP .
ANNALS OF NEUROLOGY, 1992, 31 (03) :235-241
[4]   QUANTITATIVE NUCLEAR-MAGNETIC-RESONANCE IMAGING - CHARACTERIZATION OF EXPERIMENTAL CEREBRAL EDEMA [J].
BARNES, D ;
MCDONALD, WI ;
JOHNSON, G ;
TOFTS, PS ;
LANDON, DN .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1987, 50 (02) :125-133
[5]   DISTRIBUTION OF SODIUM-CHANNELS IN CHRONICALLY DEMYELINATED SPINAL-CORD AXONS - IMMUNO-ULTRASTRUCTURAL LOCALIZATION AND ELECTROPHYSIOLOGICAL OBSERVATIONS [J].
BLACK, JA ;
FELTS, P ;
SMITH, KJ ;
KOCSIS, JD ;
WAXMAN, SG .
BRAIN RESEARCH, 1991, 544 (01) :59-70
[6]   MULTIPLE-SCLEROSIS IN CHILDREN - CEREBRAL METABOLIC ALTERATIONS MONITORED BY LOCALIZED PROTON MAGNETIC-RESONANCE SPECTROSCOPY INVIVO [J].
BRUHN, H ;
FRAHM, J ;
MERBOLDT, KD ;
HANICKE, W ;
HANEFELD, F ;
CHRISTEN, HJ ;
KRUSE, B ;
BAUER, HJ .
ANNALS OF NEUROLOGY, 1992, 32 (02) :140-150
[7]   BIOCHEMICAL-CHANGES WITHIN A MULTIPLE-SCLEROSIS PLAQUE INVIVO [J].
CADOUXHUDSON, TAD ;
KERMODE, A ;
RAJAGOPALAN, B ;
TAYLOR, D ;
THOMPSON, AJ ;
ORMEROD, IEC ;
MCDONALD, WI ;
RADDA, GK .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1991, 54 (11) :1004-1006
[8]   DETECTION OF MYELIN BREAKDOWN PRODUCTS BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY [J].
DAVIE, CA ;
HAWKINS, CP ;
BARKER, GJ ;
BRENNAN, A ;
TOFTS, PS ;
MILLER, DH ;
MCDONALD, WI .
LANCET, 1993, 341 (8845) :630-631
[9]   SERIAL PROTON MAGNETIC-RESONANCE SPECTROSCOPY IN ACUTE MULTIPLE-SCLEROSIS LESIONS [J].
DAVIE, CA ;
HAWKINS, CP ;
BARKER, GJ ;
BRENNAN, A ;
TOFTS, PS ;
MILLER, DH ;
MCDONALD, WI .
BRAIN, 1994, 117 :49-58
[10]  
DAVIES SEC, 1995, J NEUROCHEM, V64, P742